403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Zelluna ASA: Invitation To Fourth Quarter 2025 Results Webcast Presentation
(MENAFN- GlobeNewsWire - Nasdaq) Oslo, Norway, 5 February 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic“off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of its fourth quarter 2025 results on Thursday, 12 February 2026.
The presentation can be followed live via a webcast link available on at 08:30 CET on Thursday, 12 February 2026. The webcast recording will remain available on the company's website after the event, and participants will be able to submit questions during the presentation.
The quarterly report and presentation materials will be published on the company's website at 07:00 CET on the same day.
For further information, please see or contact:
For further information, please contact:
Namir Hassan, CEO, Zelluna ASA
Email: ...
Phone: +44 7720 687608
Geir Christian Melen, CFO, Zelluna ASA
Email: ...
Phone: +47 913 02 965
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment